Podcast

Pharmacy Focus Episode 36: Breaking the Stigma Surrounding Multiple Sclerosis

Diagnosis, treatment options, and the role of the pharmacist in patient care are all important factors when looking at multiple sclerosis as a whole.

In this week’s episode, we will be discussing multiple sclerosis, including diagnosis, treatment options, and the role of the pharmacist in patient care, with Dr. Tirisham Gyang and pharmacist Dr. Margaret Hansen. If you would like to nominate a pharmacist or pharmacy staff member as a Pharmacy Hero, email AAntrim@pharmacytimes.com!

Related Videos
Related Content
Varicella zoster or chickenpox virus, ai illustration. A herpes virus which cause chickenpox and shingles - Image credit: Cristina | stock.adobe.com
December 20th 2024

Study: Fatal Disseminated Herpes Zoster in Immunocompetent Individuals

Kennedy Ferruggia, Assistant Editor
Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments
November 25th 2024

Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments

FDA headquarters -- Image credit: JHVEPhoto | stock.adobe.com
December 20th 2024

FDA Approves Symvess for Treatment of Extremity Vascular Trauma

Gillian McGovern, Assistant Editor
Public Health Matters: Pharmacists as Frontline Health Providers: Collaborating for Better Patient Outcomes
November 21st 2024

Public Health Matters: Pharmacists as Frontline Health Providers: Collaborating for Better Patient Outcomes

Christina M. Madison, PharmD, FCCP, AAHIVP
Postpartum depression -- Image credit: grooveriderz | stock.adobe.com
December 20th 2024

Study: Predictive Screening Models Less Likely to Widen Existing Health Disparities in PMAD Diagnosis

Gillian McGovern, Assistant Editor
FDA Approval, Familial Chyomicronemia Syndrome | Image Credit: Tyler Olson | stock.adobe.com
December 20th 2024

FDA Approves Olezarsen as Adjunct to Diet for Familial Chylomicronemia Syndrome

Ashley Gallagher, Associate Editor